Vanguard Global Advisers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
Vanguard Global Advisers's ROIV Position: Q3 2026 in Review
Vanguard Global Advisers increased its Roivant Sciences (ROIV) stake by 20% in Q3 2026, buying an estimated $1.43M and bringing the position to 234,776 shares worth $8.59M. The position accounts for ﹤0.01% of the portfolio, ranked #649.
Vanguard Global Advisers first reported a position in ROIV in Q1 2026 and has held it in 3 quarters since. 522 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.
- Vanguard Global Advisers held 234,776 shares of Roivant Sciences worth $8.59M as of Q3 2026.
- Vanguard Global Advisers bought 39,333 Roivant Sciences shares in Q3 2026, an estimated $1.43M.
- Roivant Sciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #649 holding.
- Vanguard Global Advisers first reported a position in Roivant Sciences in Q1 2026 and has held it in 3 quarters since.
- 522 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.